# Clerio Vision

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/clerio-vision

- Industry: Medical Devices & Equipment
- Headquarters: New York, US
- Website: www.cleriovision.com
- Total disclosed funding: $5M
- Latest round: Series D (Apr 1, 2018)
- Investors on record: 3

## About

Clerio Vision Inc. develops innovative vision correction solutions utilizing proprietary LIRIC technology. The company focuses on creating advanced products for addressing various vision impairments, serving healthcare providers globally.Founded in 2014 in New York, US, Clerio Vision Inc. specializes in vision correction technology, particularly through its Laser Induced Refractive Index Change (LIRIC) platform. The company was established by Jonathan Ellis, Mikael Totterman, and Scott Catlin, and currently led by CEO Alex Zapesochny. Clerio Vision has raised a total of USD 3.00 mn, with its most recent funding round being a VENTURE DEBT round in June 2019, securing USD 11.93 mn. The company has completed six deals to date.Clerio Vision specializes in advanced vision correction solutions through its proprietary Laser Induced Refractive Index Change (LIRIC) technology. This innovative platform produces optically superior lens patterns effective in addressing common vision impairments such as presbyopia, myopia, hyperopia, astigmatism, and higher-order aberrations. The company's core offerings include contact lenses, intraocular lenses, and myopia control solutions, leveraging femtosecond laser technology originally developed from research at the University of Rochester. Clerio Vision aims to provide effective options for millions of patients seeking better vision correction, serving a global client base that includes eye care professionals, clinics, and hospitals across North America, Europe, and Asia.Clerio Vision generates revenue through the direct sale of its innovative vision correction products to healthcare providers and eye care specialists. The business model primarily involves B2B transactions, partnering with clinics and retailers to distribute its LIRIC-based solutions. Clients purchase these products for their patients, streamlining the supply chain and enhancing accessibility to advanced vision care. While specific pricing details for flagship products like advanced contact lenses and intraocular lenses are not disclosed, the firm's partnerships with eye care facilities are critical to its revenue stream, facilitating the integration of Clerio Vision's technologies into the broader healthcare system.Clerio Vision is focused on expanding its product offerings and entering new markets. The company is working on new vision correction products designed to enhance patient options, with anticipated launches in the coming years. Additionally, the firm plans to expand its reach into markets in Asia and Europe by 2025. The recent VENTURE DEBT funding of USD 11.93 mn will support these initiatives, allowing Clerio Vision to enhance its product development and market penetration strategies.

## Funding rounds

- Series D, Apr 1, 2018, $3M — Topmark Partners
- Series A, Jan 13, 2015, $2M — Topmark Partners, Armory Square Ventures, Cranberry Capital

## Investors

- Topmark Partners (https://capitalatlas.ai/funds/topmark-partners) — Series A, Series D
- Armory Square Ventures (https://capitalatlas.ai/funds/armory-square-ventures) — Series A
- Cranberry Capital (https://capitalatlas.ai/funds/cranberry-capital) — Series A